DECREASED IMMUNE RESPONSE TO COVID-19 MRNA VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI TNF?: A PROSPECTIVE, CONTROLLED, MULTI-CENTER ISRAELI STUDY

Hadar Edelman-Klapper  ¹     Eran Zittan  ²     Ariella Bar-Gil Shitrit  ³     Keren Masha Rabinowitz  ³     Idan Goren  ³     Irit Avni-Biron  ³     Lev Lichtenstein  ⁴     Hagar Banai-Eran  ⁴     Henit Yanai  ⁴     Yifat Snir  ⁴     Maor H. Pauker  ⁴     Adi Friedenberg  ⁴     Adva Levy-Barda  ⁴     Arie Segal  ⁵     Yelena Broytman  ⁵     Eran Maoz  ⁶     Baruch Ovadia  ⁷     Tsachi Tsadok Perets  ⁷     Rami Eliakim  ⁸     Meital Gal-Tanamy  ⁹     Michal Navon  ¹⁰     Noy Krugliak  ¹⁰     Natalia T. Freund  ¹⁰     Sophy Goren  ¹⁰     Iris Dotan  ¹⁰     Jacob E. Ollech  ¹⁰     Daniel E. Cohen  ^10    
1 Rabin Medical Center, Petah Tikva, Israel
² Emek Medical Center, Afula, Israel
³ Shaare Zedek Medical Center, Jerusalem, Israel
⁴ Clalit Health Services, Petah Tikva, Israel
⁵ Soroka University Medical Center, Beer Sheva, Israel
⁶ Clalit Health Services, Tel Aviv, Israel
⁷ Hillel Yaffe Medical Center, Hadera, Israel
⁸ Sheba Medical Center, Ramat-Gan, Israel
⁹ Bar Ilan University, Ramat-Gan, Israel
¹⁰ Tel Aviv University, Tel Aviv, Israel

Topic
IBD, Immunology, Paediatrics

Session
IBD: Clinical trials I

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)